Autopsy findings of amplatzer septal occluder at 5 months after closure of atrial septal defect: How long does it take to be endothelialized?

Akio Kawamura, Hideaki Kigasawa, Hiroshi Kamma

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

An 83-year-old man died of aspiration pneumonia 5 months after closure of atrial septal defect (ASD) with an Amplatzer atrial septal defect occluder (ASO). At autopsy, the device was scarcely covered by the endothelium. After percutaneous ASD closure, 6-month course of antiplatelet therapy and prophylaxis for endocarditis are recommended. However, the 6-month duration may not be sufficient for some patients. More data are required to clarify how long it takes for the ASO device to be endothelialized in the human body and to determine predictors of poor endothelialization.

Original languageEnglish
JournalJournal of Invasive Cardiology
Volume25
Issue number8
Publication statusPublished - 2013 Aug

Fingerprint

Septal Occluder Device
Atrial Heart Septal Defects
Autopsy
Aspiration Pneumonia
Endocarditis
Human Body
Endothelium
Equipment and Supplies
Therapeutics

Keywords

  • Amplatzer septal occluder
  • atrial septal defect

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Autopsy findings of amplatzer septal occluder at 5 months after closure of atrial septal defect : How long does it take to be endothelialized? / Kawamura, Akio; Kigasawa, Hideaki; Kamma, Hiroshi.

In: Journal of Invasive Cardiology, Vol. 25, No. 8, 08.2013.

Research output: Contribution to journalArticle

@article{a01ac21a12314e63bb6babe246dd1de4,
title = "Autopsy findings of amplatzer septal occluder at 5 months after closure of atrial septal defect: How long does it take to be endothelialized?",
abstract = "An 83-year-old man died of aspiration pneumonia 5 months after closure of atrial septal defect (ASD) with an Amplatzer atrial septal defect occluder (ASO). At autopsy, the device was scarcely covered by the endothelium. After percutaneous ASD closure, 6-month course of antiplatelet therapy and prophylaxis for endocarditis are recommended. However, the 6-month duration may not be sufficient for some patients. More data are required to clarify how long it takes for the ASO device to be endothelialized in the human body and to determine predictors of poor endothelialization.",
keywords = "Amplatzer septal occluder, atrial septal defect",
author = "Akio Kawamura and Hideaki Kigasawa and Hiroshi Kamma",
year = "2013",
month = "8",
language = "English",
volume = "25",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "HMP Communications",
number = "8",

}

TY - JOUR

T1 - Autopsy findings of amplatzer septal occluder at 5 months after closure of atrial septal defect

T2 - How long does it take to be endothelialized?

AU - Kawamura, Akio

AU - Kigasawa, Hideaki

AU - Kamma, Hiroshi

PY - 2013/8

Y1 - 2013/8

N2 - An 83-year-old man died of aspiration pneumonia 5 months after closure of atrial septal defect (ASD) with an Amplatzer atrial septal defect occluder (ASO). At autopsy, the device was scarcely covered by the endothelium. After percutaneous ASD closure, 6-month course of antiplatelet therapy and prophylaxis for endocarditis are recommended. However, the 6-month duration may not be sufficient for some patients. More data are required to clarify how long it takes for the ASO device to be endothelialized in the human body and to determine predictors of poor endothelialization.

AB - An 83-year-old man died of aspiration pneumonia 5 months after closure of atrial septal defect (ASD) with an Amplatzer atrial septal defect occluder (ASO). At autopsy, the device was scarcely covered by the endothelium. After percutaneous ASD closure, 6-month course of antiplatelet therapy and prophylaxis for endocarditis are recommended. However, the 6-month duration may not be sufficient for some patients. More data are required to clarify how long it takes for the ASO device to be endothelialized in the human body and to determine predictors of poor endothelialization.

KW - Amplatzer septal occluder

KW - atrial septal defect

UR - http://www.scopus.com/inward/record.url?scp=84882429583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882429583&partnerID=8YFLogxK

M3 - Article

C2 - 23913613

AN - SCOPUS:84882429583

VL - 25

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 8

ER -